The discrepancy between the increased mRNA but no increase in protein levels of Bim in D2/CA-only treated AML cells can be explained by the previous observation that Bim mRNA is known to be targeted by miR32, which prevents its translation [38]. This evidence concerns the gene BCL2L11 and acute myeloid leukemia.